| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Dec 4, 2023 | Viracta Therapeutics, Inc. | CEO | Buy | 91.3 | +100,000 | 100.00% | ✗ | $49.4K |
| Mar 3, 2016 | Mar 7, 2016 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Buy | 91.3 | +2,000 | 16.21% | ✗ | $12.5K |
| Mar 17, 2015 | Mar 18, 2015 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 7.5 | -10,700 | -100.00% | ✓ | $820K |
| Mar 13, 2015 | Mar 13, 2015 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 13.8 | -300 | -100.00% | ✓ | $22.9K |
| Feb 23, 2015 | Feb 25, 2015 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 5.0 | -35,000 | -58.33% | ✓ | $2.4M |
| Jan 20, 2015 | Jan 22, 2015 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 10.0 | -3,000 | -50.00% | ✓ | $180.1K |
| Jan 16, 2015 | Jan 16, 2015 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 10.0 | -2,300 | -27.71% | ✓ | $134.9K |
| Jan 13, 2015 | Jan 15, 2015 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 7.5 | -9,700 | -35.02% | ✓ | $563K |
| Sep 24, 2014 | Sep 26, 2014 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 17.5 | -16,000 | -19.05% | ✓ | $714.2K |
| Sep 15, 2014 | Sep 16, 2014 | PTC THERAPEUTICS, INC. | Chief Commercial Officer | Sell | 7.5 | -8,000 | -32.00% | ✓ | $289.9K |